Candida parapsilosis in Late Prosthetic Joint Infections Among Immunocompetent Patients: A Case Series

James C George1, B Samuel Chittaranjan1, Subin Babu1

  • 1Department of Orthopaedic Surgery, Believers Church Medical College Hospital, Pathanamthitta, Kerala, India.

Abstract

Insights

Fungal prosthetic joint infections (PJIs) are rare in immunocompetent individuals. Late-presenting fungal PJIs can be successfully managed with debridement, extended cultures, and long-term antifungal therapy, preventing recurrence.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Mycology

Background:

  • Fungal prosthetic joint infections (PJIs) are uncommon, particularly in immunocompetent patients.
  • Late-presenting fungal PJIs often mimic aseptic loosening, complicating diagnosis due to challenges in pathogen isolation.
  • Current management guidelines for these specific cases are lacking.

Purpose of the Study:

  • To report on the clinical presentation and management of five cases of late-chronic prosthetic joint infections caused by Candida parapsilosis.
  • To highlight the diagnostic challenges and treatment outcomes for fungal PJIs in immunocompetent individuals.

Main Methods:

  • Retrospective case series of five immunocompetent patients with culture-negative, late-presenting fungal PJIs.
  • Involved extensive surgical debridement, meticulous intraoperative sampling for extended fungal cultures.
  • Treatment consisted of long-term antifungal therapy post-debridement.

Main Results:

  • All five patients presented with late chronic PJI, were immunocompetent, and culture-negative preoperatively.
  • Three knee and two hip hemiarthroplasty PJIs were identified.
  • All patients achieved successful outcomes with no disease reactivation or recurrence during follow-up after treatment with antifungals.

Conclusions:

  • Fungal PJI should be considered in immunocompetent patients presenting with aseptic loosening symptoms without typical signs of infection.
  • Surgical revision combined with extended antifungal suppressive therapy can yield favorable results in managing late fungal PJIs.